Behcet’s disease: from heat shock proteins to infections

1. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behcet’s disease: from Hippocrates to the third millennium. Brit J Ophthalmol. 2003; 87:1175-83.10.1136/bjo.87.9.1175Open DOISearch in Google Scholar

2. Onder M, Gurer MA. Behcet’s disease: an enigmatic vasculitis. Clin Dermatol. 1999; 17:571-6.10.1016/S0738-081X(99)00063-2Open DOISearch in Google Scholar

3. Evereklioglu C. Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol. 2005; 50:297-350.10.1016/j.survophthal.2005.04.00915967189Open DOISearch in Google Scholar

4. Direskeneli H. Behcet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001; 60:996-1002.10.1136/ard.60.11.996175340511602462Open DOISearch in Google Scholar

5. Mumcu G, Inanc N, Yavuz S, Direskeneli H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet’s disease. Clin Exp Rheumatol. 2007; 25:S27-33.Search in Google Scholar

6. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet’s disease. Clin Exp Immunol. 2005; 139:371-8.10.1111/j.1365-2249.2005.02695.x180927715654837Open DOISearch in Google Scholar

7. Amoura Z, Guillaume M, Caillat-Zucman S, Wechsler B, Piette JC. Pathophysiology of Behcet’s disease (Physiopathologie de la maladie de Behcet). Rev Med Interne. 2006; 27:843-53.10.1016/j.revmed.2006.02.01416828934Open DOISearch in Google Scholar

8. Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro-Behcet Disease. Neurologist. 2005; 11:80-9.10.1097/01.nrl.0000156343.16797.c415733330Open DOISearch in Google Scholar

9. Zouboulis CC. HLA-independent antibacterial host response toward Th1 immunity mediated by IL-12: a new concept for the pathogenesis of Adamantiades- Behcet’s disease. J Invest Dermatol. 2006; 126:1444-7.10.1038/sj.jid.570028116778812Open DOISearch in Google Scholar

10. Yabuki K, Mizuki N, Ota M, Katsuyama Y, Palimeris G, Stavropoulos C, et al. Association of MICA gene and HLA-B*5101 with Behcet’s disease in Greece. Invest Ophthalmol Vis Sci. 1999; 40:1921-6.Search in Google Scholar

11. Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, et al. Human genome and diseases: review- immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci. 2003; 60:1903-22.10.1007/s00018-003-2333-314523551Open DOISearch in Google Scholar

12. Kalayciyan A, Zouboulis CC. An update on Behcet’s disease. J Eur Acad Dermatol Venereol. 2006; 21:1-10.10.1111/j.1468-3083.2006.01863.x17207160Search in Google Scholar

13. Gul A. Standard and novel therapeutic approaches to Behcet’s disease. Drugs. 2007; 67:2013-22.10.2165/00003495-200767140-0000417883285Open DOISearch in Google Scholar

14. Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC. Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - Current pathogenetic concepts and therapeutic possibilities. J German Soc Dermatol. 2006; 4:49-66.10.1111/j.1610-0387.2006.05841.x16503932Search in Google Scholar

15. Zouboulis CC, May T. Pathogenesis of Adamantiades- Behcet’s disease. Med Microbiol Immunol. 2003; 192: 149-55.10.1007/s00430-002-0167-512684757Open DOISearch in Google Scholar

16. Zouboulis CC, Turnbull JR, Muhlradt PF. High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol. 2003; 121:211-2.10.1046/j.1523-1747.2003.12303.x12839585Search in Google Scholar

17. Belizna CC, Hamidou MA, Levesque H, Guillevin L, Shoenfeld Y. Infection and vasculitis. Rheumatology. 2009; 48:475-82.10.1093/rheumatology/kep026710723719258377Search in Google Scholar

18. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behcet’s disease. Eur J Dermatol. 2008; 18:489-98.Search in Google Scholar

19. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behcet’s disease (editorial). Clin Exp Rheumatol. 1995; 13:687-91.Search in Google Scholar

20. Deutera CME, Kotter I, Wallace GR, Murray PI, Stubiger N, Zierhut M. Behcet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008; 27: 111-36.10.1016/j.preteyeres.2007.09.00218035584Open DOISearch in Google Scholar

21. Onder M, Gurer MA. The multiple faces of Behcet’s disease and its aetiological factors. J Eur Acad Dermatol Venerol. 2001; 15:126-36.10.1046/j.1468-3083.2001.00251.x11495519Open DOISearch in Google Scholar

22. Mizuki N, Ohno SH. Immunogenetic studies of Behcet’s disease. Revue du rhumatisme. 1996; 63: 520-7.Search in Google Scholar

23. Barnes CG. Behcet’s syndrome. Top Rev. 1991; 18.Search in Google Scholar

24. Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, et al. Oral health is impaired in Behcet’s disease and is associated with disease severity. Rheumatology. 2004; 43:1028-33.10.1093/rheumatology/keh23615161982Open DOISearch in Google Scholar

25. Akman A, Sallakci N, Kacaroglu H, Tosun O, Yavuzer U, Alpsoy E, et al. Relationship between periodontal findings and the TNF-á Gene 1031T/C polymorphism in Turkish patients with Behcet’s disease. J Eur Acad Dermatol Venereol. 2008; 22:950-7.10.1111/j.1468-3083.2008.02678.x18355201Open DOISearch in Google Scholar

26. Arabaci T, Kara C, Cicek Y. Relationship between periodontal parameters and Behcet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis. J Periodont Res. 2009; 44:718-25.10.1111/j.1600-0765.2008.01183.x19076988Open DOISearch in Google Scholar

27. Mizushima Y, Hoshi K, Matsuda T, Takahashi M, Takada H, Kuribayashi S, et al. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet’s disease-a multicenter study. The Behcet’s Disease Research Committee of Japan. J Rheumatol. 1989; 16: 506-11.Search in Google Scholar

28. Tsuchida M, Mineshita S, Okonogi H, Sugimor K, Hoshi K, Horiuchi T, et al. The role of an uncommon type of oral Streptococcus Sanguis in the etiology of Behcet’s disease. Environ Health Prev Med. 1997; 2:59-63.10.1007/BF02931965Open DOISearch in Google Scholar

29. Mizushima Y, Matsuda T, Hoshi K, Ohno S. Induction of Behcet’s disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol. 1988; 15:1029-30.Search in Google Scholar

30. Choi SM, Choi YJ, Kim JT, Lee SH, Park MS, Kim BC, et al. A case of recurrent neuro-Behcet’s disease after tooth extraction. J Korean Med Sci. 2010; 25:185-7.10.3346/jkms.2010.25.1.185Open DOISearch in Google Scholar

31. Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H, et al. The close association between dental and periodontal treatments and oral ulcer course in Behcet’s disease: a prospective clinical study. J Oral Pathol Med. 2009; 38:410-5.10.1111/j.1600-0714.2009.00765.xOpen DOISearch in Google Scholar

32. Baharav E, Weinberger A, Mor F. Experimental models of Behcet’s disease. Drug Discov Today: Disease Model. 2006; 3:11-4.10.1016/j.ddmod.2006.03.008Search in Google Scholar

33. Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y. Streptococcus oralis previously identified as uncommon ‘Streptococcus sanguis’ in Behcet’s disease. Arch Oral Biol. 1995; 40: 685-90.10.1016/0003-9969(95)00042-NOpen DOISearch in Google Scholar

34. Yoshikawa K, Kotake S, Kubota T, Kimura K, Isogai E, Fujii N. Cloning and sequencing of BES-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behcet’s disease. Zentralblatt fur Bakteriologie. 1998; 287: 449-60.10.1016/S0934-8840(98)80184-9Search in Google Scholar

35. Tojo M, Yanagihori H, Zheng X, Oyama N, Isogai E, Kimura K, et al. Bes-1 DNA fragment encoding streptococcal antigen in skin lesions from patients with Behcet’s disease. J Appl Res Clin Exp Ther. 2003; 3:232-8.Search in Google Scholar

36. Kurauchi T, Yokota K, Matsuo T, Fujinami Y, Isogai E, Isogai H, et al. Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behcet’s disease. FEMS Immunol Med Microbiol. 2005; 43: 125-31.10.1016/j.femsim.2004.07.00715681141Open DOISearch in Google Scholar

37. Yanagihori H, Oyama N, Nakamura K, Mizuki N, Oguma K, Kaneko F. Role of IL-12B promoter polymorphism in Adamantiades-Behcet’s disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol. 2006; 126:1534-40.10.1038/sj.jid.570020316514412Open DOISearch in Google Scholar

38. Oh SH, Lee KY, Lee JH, Bang D. Clinical manifestations associated with high titer of anti-streptolysin O in Behcet’s disease. Clin Rheumatol. 2008; 27:999-1003.10.1007/s10067-008-0844-x18246379Open DOISearch in Google Scholar

39. Yokota K, Hayashi S, Fuji N, Yoshikawa K, Kotake S, Isogai E, et al. Antibody response to oral Streptococci in Behcet’s disease. Microbiol Immunol. 1992; 36: 815-22.10.1111/j.1348-0421.1992.tb02083.x1474932Open DOISearch in Google Scholar

40. Namba K, Ueno T, Okita M. Behcet’s disease and streptococcal infection. Jpn J Ophthalmol. 1986; 30: 385-401.Search in Google Scholar

41. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-ã by T cells from patients with Behcet’s disease. Cell Immunol. 1992; 140:410-9.10.1016/0008-8749(92)90207-6Open DOISearch in Google Scholar

42. Isogai E, Isogai H, Kotake S, Ohno S, Kimura K, Oguma K. Role of Streptococcus sanguis and traumatic factors in Behcet’s disease. J Appl Res Clin Exp Ther. 2003; 3:64-75.Search in Google Scholar

43. Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu S, et al. The pustular skin lesions in Behcet’s syndrome are not sterile. Ann Rheum Dis. 2004; 63:1450-2.10.1136/ard.2003.017467Open DOISearch in Google Scholar

44. Suga Y, Tsuboi R, Kobayashi S, Ogawa H. A case of Behcet’s disease aggravated by gingival infection with methicillin-resistant Staphylococcus aureus. Brit J Dermatol. 1995; 133:319-21.10.1111/j.1365-2133.1995.tb02640.xOpen DOISearch in Google Scholar

45. Keser G, Erdogan M, Aydemir S, Karatas T, Aksu K, Tunger A, et al. Nasal Staphylococcus aureus carriage is not increased in Behcet’s disease. Rheumatol Int. 2005; 25:567-8.10.1007/s00296-005-0593-yOpen DOISearch in Google Scholar

46. Onen F, Tuncer D, Akar S, Birlik M, Akkoc N. Seroprevalence of Borrelia burgdorferi in patients with Behcet’s disease. Rheumatol Int. 2003; 23:289-93.10.1007/s00296-003-0313-4Open DOISearch in Google Scholar

47. Isogai E, Isogai H, Kotake S, Yoshikawa K, Ichiishi A, Kosaka S, et al. Detection of antibodies against Borrelia burgdorferi in patients with uveitis. Am J Ophthalmol. 1991; 112:23-30.10.1016/S0002-9394(14)76207-5Open DOISearch in Google Scholar

48. Ayaslioglu E, Erkek E, Kaygusuz S, Kilic D, Inal A, Keskun G. Analysis of Borrelia Burgdorferi antibody seroprevalence in patients with Behcet’s disease using 3 different serological assays. Turk J Med Sci. 2004; 34:375-8.Search in Google Scholar

49. di Meo N, Quaranta L, Crisman G, Trevisan G. Adamantiades Behcet disease triggered by a tick bite and or borrelia infection. J Eur Acad Dermatol Venereol. 2009; 23:1198-9.10.1111/j.1468-3083.2009.03105.x19573027Search in Google Scholar

50. Iliopoulos A, Kedikoglou S, Laxanis S, Kourouklis S, Katsaros E. A case of tuberculous meningoencephalitis in a patient with Behcet’s disease. Clin Rheumatol. 2005; 25:121-2.10.1007/s10067-005-1135-415902513Search in Google Scholar

51. Apan TZ, Gursel R, Dolgun A. Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behcet’s disease. Clin Rheumatol. 2007; 26:885-9.10.1007/s10067-006-0416-x17021670Open DOISearch in Google Scholar

52. Yildirim B, Ozturk MA, Unal S. The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet’s syndrome. Rheumatol Int. 2009; 29:477-8.10.1007/s00296-008-0709-218802701Open DOISearch in Google Scholar

53. Avc O, Ellidokuz E, Imek I, Buyukgebiz B, Gune AT. Helicobacter pylori and Behcet’s disease. Dermatology. 1999; 199:140-3.10.1159/000018221Open DOISearch in Google Scholar

54. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S. H. pylori infection in patients with Behcet’s disease. World J Gastroenterol. 2007; 13:2983-5.10.3748/wjg.v13.i21.2983Open DOISearch in Google Scholar

55. Cakmak SK, Cakmak A, Gul U, Sulaimanov M, Bingol P, Hazinedarolu MS. Upper gastrointestinal abnormalities and Helicobacter pylori in Behcet’s disease. Int J Dermatol. 2009; 48:1174-6.10.1111/j.1365-4632.2009.04145.xOpen DOISearch in Google Scholar

56. Gunduz A, Gunduz A, Cumurcu T, Seyrek A. Conjunctival flora in Behcet patients. Can J Ophthalmol. 2008; 43: 476-9.10.3129/i08-089Open DOISearch in Google Scholar

57. Ayaslioglu E, Duzgun N, Erkek E, Inal A. Evidence of chronic Chlamydia pneumoniae infection in patients with Behcet’s disease. Scand J Infect Dis. 2004; 36: 428-30.10.1080/00365540410020730Open DOISearch in Google Scholar

58. Mandal K, Jahangiri M, Xu Q. Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev. 2004; 3:31-7.10.1016/S1568-9972(03)00088-0Open DOISearch in Google Scholar

59. Hauet-Broere F, Wieten L, Guichelaar T, Berlo S, van der Zee R, Van Eden W. Heat shock proteins induce T cell regulation of chronic inflammation. Ann Rheum Dis. 2006; 65 (Suppl III):iii65-8.10.1136/ard.2006.058495Search in Google Scholar

60. Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet’s disease. Clin Exp Rheumatol. 2003; 4 (Suppl):S44-8.Search in Google Scholar

61. Zierhut M, Mizuki N, Ohno S, Inoko H, Gul A, Onoe K, et al. Immunology and functional genomics of Behcet’s disease. Cell Mol Life Sci. 2003; 60:1903-22.10.1007/s00018-003-2333-3Open DOISearch in Google Scholar

62. Saruhan-Direskeneli G, Celet B, Eksioglu-Demiralp E, Direskeneli H. Human HSP 60 peptide responsive T cell lines are similarly present in both Behcet’s disease patients and healthy controls. Immunol Lett. 2001; 79:203-8.10.1016/S0165-2478(01)00280-2Search in Google Scholar

63. Shaker O, Ay El-Deen MA, El Hadidi H, Grace BD, El Sherif H, Abdel Halim A. The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behcet’s disease. Brit J Dermatol. 2007; 156:32-7.10.1111/j.1365-2133.2006.07536.x17199563Search in Google Scholar

64. Lund PA, Large AT, Kapatai G. The chaperonins: perspectives from the Archaea. Biochem Soc Trans. 2003; 31:681-85.10.1042/bst031068112773182Open DOISearch in Google Scholar

65. Deniz E, Guc U, Buyukbabani N, Gul A. HSP 60 expression in recurrent oral ulcerations of Behcet’s disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110:196-200.10.1016/j.tripleo.2010.03.02020580281Search in Google Scholar

66. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behcet’s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int. 2007; 27:417-24.10.1007/s00296-006-0281-617171346Open DOISearch in Google Scholar

67. Celet B, Akman-Demir G, Serdaroglu P, Yentur SP, Tas’ci B, Van Noort JM, et al. Anti-áB-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol. 2000; 247:935-9.10.1007/s00415007004911200685Search in Google Scholar

68. Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L, et al. HSP 60 expression in mucocutaneous lesions of Behcet’s disease. J Am Acad Dermatol. 2001; 45:904-9.10.1067/mjd.2001.11772811712037Search in Google Scholar

69. Kurokawa MS, Suzuki N. Behcet’s disease. Clin Exp Med. 2004; 3:10-20.10.1007/s10238-004-0033-415598081Open DOISearch in Google Scholar

70. Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H. Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behcet’s disease. Clin Exp Rheumatol. 2008; 26:S96-8.Search in Google Scholar

71. Karadag R, Koca C, Totan Y, Yagci R, Aydin M, Karadag AS, et al. Comparison of serum levels of IL-6, IL-8, TNF-á, C reactive protein and heat shock protein 70 in patients with active or inactive Behcet’s disease. Turk J Med Sci. 2010; 40:57-62.10.3906/sag-0906-3Search in Google Scholar

72. Yavuz S, Elbir Y, Tulunay A, Eksioglu-Demiralp E, Direskeneli H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet disease etiopathogenesis. Rheumatol Int. 2008; 28:401-6.10.1007/s00296-007-0470-y17934735Open DOISearch in Google Scholar

73. Kirino Y, Takeno M, Watanabe R, Murakami S, Kobayashi M, Ideguchi H, et al. Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behcet’s disease. Arthritis Res Ther. 2008; 10: R16.10.1186/ar2367237447218234118Search in Google Scholar

74. Lancaster GI, Febbraio MA. Mechanisms of stressinduced cellular HSP72 release. In: Asea AAA, De Maio A, editors. Heat shock proteins: potent mediators of inflammation and immunity. The Netherlands, Dordrecht: Springer; 2007, p. 31-7.10.1007/978-1-4020-5585-0_3Search in Google Scholar

75. Meguro A, Ota M, Katsuyama Y, Oka A, Ohno S, Inoko H, et al. Association of the toll-like receptor 4 gene polymorphisms with Behcet’s disease. Ann Rheum Dis. 2008; 67:725-7.10.1136/ard.2007.07987118408113Search in Google Scholar

76. Miura T, Ishihara K, Kato T, Kimizuka R, Miyabe H, Ando T, et al. Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behcet’s disease. Oral Microbiol Immunol. 2005; 20:167-71.10.1111/j.1399-302X.2005.00207.xOpen DOISearch in Google Scholar

77. Van Eden W. Heat shock proteins are targets for T cell regulation: how microbial HSP induce IL10 producing anti-inflammatory T cells. In: Asea AAA, De Maio A, editors. Heat shock proteins: potent mediators of inflammation and immunity. The Netherlands, Dordrecht: Springer; 2007, p. 289-308.10.1007/978-1-4020-5585-0_18Search in Google Scholar

78. Fortune F, Walker J, Lefrancois M, Lehner T. The expression of carbohydrate antigens in activated T cells and in autoimmune diseases. Scand J Immunol. 1994, 40:636-42.10.1111/j.1365-3083.1994.tb03516.xOpen DOISearch in Google Scholar

79. Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behcet’s disease: immunological aspects. Yonsei Med J. 1997, 38:350-8.10.3349/ymj.1997.38.6.350Open DOISearch in Google Scholar

80. Escudier M, Bagan J, Scully C. Mucosal diseases series: number VII Behcet’s disease (Adamantiades syndrome). Oral Dis. 2006, 12:78-84.10.1111/j.1601-0825.2005.01144.xOpen DOISearch in Google Scholar

81. Direskeneli H. Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder? Rheumatology. 2006; 45:1461-5.10.1093/rheumatology/kel329Open DOISearch in Google Scholar

82. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, et al. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet’s disease (BD) in Japan. Clin Exp Immunol. 1997; 108:204-12.10.1046/j.1365-2249.1997.3611265.xSearch in Google Scholar

83. Pervin K, Childerstone A, Shinnick T, Mizushima Y, Van der Zee R, Hasan A, et al. T cell epitope expression of mycobacterial and homologous human 65- kilodalton heat shock protein peptides in short term cell lines from patients with Behcet’s disease. J Immunol. 1993; 151:2273-82.Search in Google Scholar

84. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, et al. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet’s disease. J Rheumatol. 2000; 27: 708-13.Search in Google Scholar

85. Lehner T, Lavery E, Smith R, Van Der Zee R, Mizushima Y, Shinnick T. Association between the 65-kilodalton heat shock protein, Streptococcus sanguinis, and the corresponding antibodies in Behcet’s syndrome. Infect Immun. 1991; 59:1434-41.10.1128/iai.59.4.1434-1441.1991Search in Google Scholar

86. Gaston JSH, Hasan A, Fortune F, Wilson A, Lehner T. Role of ãäT cells in Behcet’s disease. Lancet. 1996; 347:1631-2.10.1016/S0140-6736(96)91121-6Open DOISearch in Google Scholar

87. Uchio E, Stanford M, Hasan A, Satoh S, Ohno S, Shinnick T, et al. HSP-derived peptides inducing uveitis and IgG and IgA antibodies. Exp Eye Res. 1998; 67:719-27.10.1006/exer.1998.05749990336Open DOISearch in Google Scholar

88. Hu W, Hasan A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, et al. Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol. 1998; 28:2444-55.10.1002/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-NSearch in Google Scholar

89. Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet’s disease. Clin Exp Immunol. 2004; 137:201-8.10.1111/j.1365-2249.2004.02520.xSearch in Google Scholar

90. Nagafuchi H, Takeno M, Yoshikawa H, Kurokawa MS, Nara K, Takada E, et al. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet’s disease. Clin Exp Immunol. 2005; 139:363-70.10.1111/j.1365-2249.2004.02688.xOpen DOISearch in Google Scholar

91. G⃞l A. Behcet’s disease: An update on the pathogenesis. Clin Exp Rheumatol. 2001; 19:S6-12.Search in Google Scholar

92. Tanaka T, Yamakawa N, Koike N, Suzuki J, Mizuno F, Usui M. Behcet’s disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm. 1999; 7:69-74.10.1076/ocii.7.2.69.4018Search in Google Scholar

93. Kim H. Diagnostic significance of antibodies to heat shock proteins. Clin Chim Acta. 2003; 337:1-10.10.1016/S0009-8981(03)00340-1Open DOISearch in Google Scholar

94. Isogai E, Isogai H, Kotake S, Ohno S, Ishihara M, Aoki K, et al. Antibody cross reactivity from sera of patients with Behcet’s disease with synthetic peptides that have homologies with proteins from Streptococcus sanguinis. J Appl Res. 2002; 2.Search in Google Scholar

95. Tasci B, Direskeneli H, Serdaroglu P, Akman-Demir G, Eraksoy M, Saruhan-Direskeneli G. Humoral immune response to mycobacterial heat shock proteins (hsp) 65 in the cerebrospinal fluid of neuro-Behcet’s patients. Clin Exp Immunol. 1998; 113:100-4.10.1046/j.1365-2249.1998.00620.xOpen DOISearch in Google Scholar

96. Ramadan A, Nussenblatt RB, de Smet MD. Elevation of anti-heat shock protein 70 antibodies in patients with uveitis. Invest Ophthalmol Vis Sci. 1996; 37: S458.Search in Google Scholar

97. Yurdakul S, Yazici H. Behcet’s syndrome. Best Pract Res Clin Rheumatol. 2008; 22:793-809.10.1016/j.berh.2008.08.005Open DOISearch in Google Scholar

98. Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet’s disease. Arthritis Rheum. 1996; 39: 2062-5.10.1002/art.1780391216Open DOISearch in Google Scholar

99. Calguneri M, Ertenli I, Kiraz S, Erman M, Celik I. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet’s disease. Dermatology. 1996; 192:125-8.10.1159/000246336Open DOISearch in Google Scholar

100. Mumcu G, Ergun T, Elbir Y, Eksioglu-Demiralp E, Yavuz S, Atalay T, et al. Clinical and immunological effects of azithromycin in Behcet’s disease. J Oral Pathol Med. 2005; 34:13-6.10.1111/j.1600-0714.2004.00265.xOpen DOISearch in Google Scholar

101. Kaneko F, Oyama N, Nishibu A. Streptococcal infection in the pathogenesis of Behcet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J. 1997; 38:444-54.10.3349/ymj.1997.38.6.444Open DOISearch in Google Scholar

102. Rozin AP, Hatemi G, Yazici H. Is Behcet’s syndrome associated with infection? (multiple letters). Ann Rheum Dis. 2005; 64:513-5.Search in Google Scholar

103. Lee S, Bang D, Cho YH, Lee ES, Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet’s disease. Arch Dermatol Res. 1996; 288:179-83.10.1007/BF02505221Open DOISearch in Google Scholar

104. Tojo M, Zheng X, Yanagihori H, Oyama N, Takahashi K, Nakamura K, et al. Detection of herpes virus genomes in skin lesions from patients with Behcet’s disease and other related inflammatory diseases. Acta Derm Venereol. 2003; 83:124-7.10.1080/00015550310007472Open DOISearch in Google Scholar

105. Lee ES, Lee S, Bang D, Sohn S. Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behcet’s disease. Revue du Rhumatisme. 1996; 63:531.Search in Google Scholar

106. Bang D, Cho YH, Choi HJ, Lee S, Sohn S. Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patients with Behcet’s disease. Revue du Rhumatisme. 1996; 63:532.Search in Google Scholar

107. Studd M, McCance DJ, Lehner T. Detection of HSV-1 DNA in patients with Behcet’s syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol. 1991; 34:39-43.10.1099/00222615-34-1-39Open DOISearch in Google Scholar

108. Nomura Y, Kitteringham N, Shiba K, Goseki M, Kimura A, Mineshita S. Use of the highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Behcet disease patients. J Med Dent Sci. 1998; 45:51-8.Search in Google Scholar

109. Sohn S, Lee ES, Bang D, Lee S. Behcet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol. 1998; 8:21-3.Search in Google Scholar

110. Sohn S, Lee ES, Kwon HJ, Lee SI, Bang D, Lee S. Expression of Th2 cytokines decreases the development of and improves Behcet’s disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis. 2001; 183:1180-6.10.1086/319681Open DOISearch in Google Scholar

111. Lee SI, Kwon HJ, Lee ES, Yang BC, Bang D, Lee S, et al. Using pCIN-mIL-4 DNA vector to express mRNA and protein and to improve herpes simplex virusinduced Behcet’s disease symptoms in mice. Vaccine. 2007; 25:7047-55.10.1016/j.vaccine.2007.07.062Open DOISearch in Google Scholar

112. Sohn S, Lee ES., Lee S. The correlation of MHC haplotype and development of Behcet’s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci. 2001; 26:173-81.10.1016/S0923-1811(01)00086-XOpen DOISearch in Google Scholar

113. Lee ES, Kim YA, Kwon HJ, Bang D, Lee S, Sohn S. Thalidomide upregulates macrophage inflammatory protein-1a in a herpes simplex virus-induced Behcet’s disease-like animal model. Arch Dermatol Res. 2004; 296:175-81.Search in Google Scholar

114. Bang D, Choi B, Kwon HJ, Lee ES, Lee S, Sohn S. Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet’s disease mouse model. Eur J Pharmacol. 2008; 598:112-7.10.1016/j.ejphar.2008.09.00518823974Open DOISearch in Google Scholar

115. Shim J, Byun HO, Lee YD, Lee ES, Sohn S. Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet’s disease-like mouse model. Gene Ther. 2009; 16:415-25.10.1038/gt.2008.18019092856Open DOISearch in Google Scholar

116. Sohn S, Lutz M, Kwon HJ, Konwalinka G, Lee S, Schirmer M. Therapeutic effects of gemcitabine on cutaneous manifestations in an Adamantiades- Behcet’s disease-like mouse model. Exp Dermatol. 2004; 13:630-4.10.1111/j.0906-6705.2004.00210.x15447723Open DOISearch in Google Scholar

117. Choi B, Hwang Y, Kwon HJ, Lee ES, Park KS, Bang D, et al. Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci. 2008; 52:87-97.10.1016/j.jdermsci.2008.05.001Open DOISearch in Google Scholar

118. Sohn S, Bang D, Lee SI, Kim YA, Lee ES, Ha JY, et al. Combined treatment with colchicine and Herba Taraxaci (Tarazacum mongolicum Hand.-Mazz.) attenuates Behcet’s disease-like symptoms in mice and influences the expressions of cytokines. Int Immunopharmacol. 2003; 3:713-21.10.1016/S1567-5769(03)00071-7Open DOISearch in Google Scholar

119. Eglin RP, Lehner T, Subak-Sharpe JH. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet’s syndrome and recurrent oral ulcers. Lancet. 1982; 2: 1356-61.10.1016/S0140-6736(82)91268-5Open DOISearch in Google Scholar

120. Sugata K, Enomoto Y, Sugiyama H, Fujita A, Miyake F, Asano Y, et al. Single episode of Behcet’s diseaselike symptoms caused by herpes simplex virus reactivation. Pediatr Int. 2009; 51:577-8.10.1111/j.1442-200X.2009.02869.x19674368Open DOISearch in Google Scholar

121. Sanchez Roman J, Castillo Palma MJ, Torronteras Santiago R, Varela Aguilar JM, Lopez Checa F, Sanchez Garcia F. Type I herpes virus, HLA phenotype and Behcet disease [Virus herpes tipo I, fenotipo HLA y enfermedad de Behcet.] Medicina Clinica. 1992; 98:366-8.Search in Google Scholar

122. Sohn S, Bang D, Lee ES, Kwon HJ, Lee SI, Lee S. Experimental studies on the antiviral agent famciclovir in Behcet’s disease symptoms in ICR mice. Brit J Dermatol. 2001; 145:799-804.10.1046/j.1365-2133.2001.04498.x11736905Open DOISearch in Google Scholar

123. Sun A, Chang JG, Kao CL, Liu BY, Wang JT, Chu CT, et al. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behcet’s disease. J Oral Pathol Med. 1996; 25:212-8.10.1111/j.1600-0714.1996.tb01374.x8835817Open DOISearch in Google Scholar

124. Lee EB, Kwon YJ, Shin KC, Song YW, Park CG, Hwang ES, et al. Decreased serum level of antibody against human cytomegalovirus in patients with Behcet’s disease. Rheumatol Int. 2005; 25:33-6.10.1007/s00296-003-0394-014600786Open DOISearch in Google Scholar

125. Akdeniz S, Harman M, Atmaca S, Akpolat N. The seroprevalence of varicella zoster antibodies in Behcet’s and other skin diseases. Eur J Epidemiol. 2003; 18:91-3.10.1023/A:1022537209948Search in Google Scholar

126. Aksu K, Kabasakal Y, Saymer A, Keser G, Oksel F, Bilgic A, et al. Prevalences of hepatitis A, B, C and E viruses in Behcet’s disease. Rheumatology. 1999; 38: 1279-81.10.1093/rheumatology/38.12.127910587560Open DOISearch in Google Scholar

127. Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Dermatol Venereol. 1998; 10:12-21.10.1111/j.1468-3083.1998.tb00922.xOpen DOISearch in Google Scholar

128. Erkek E, Ayaslioglu E, Erkek AB, Kurtipek GS, Bagci Y. Response to vaccination against hepatitis B in patients with Behcet’s disease. J Gastroenterol Hepatol. 2005; 20:1508-11.10.1111/j.1440-1746.2005.03903.x16174066Open DOISearch in Google Scholar

129. Ozkan S, Toklu T, Ilknur T, Abacioglu H, Soyal MC, Gunes AT. Is there any association between hepatitis G virus (HGV), other hepatitis viruses (HBV, HCV) and Behcet’s disease? J Dermatol. 2005, 32:361-4.10.1111/j.1346-8138.2005.tb00907.x16043898Open DOISearch in Google Scholar

130. Farajzadeh S, Shakibi MR, Moghaddam SD, Rahnama Z. Behcet disease: clinical spectrum and association with hepatitis B and C viruses. East Mediterr Health J. 2005; 11:68-72.Search in Google Scholar

131. Kiraz S, Ertenli I, Benekli M, Calguneri M. Parvovirus B19 infection in Behcet’s disease. Clin Exp Rheumatol. 1996; 14:71-3.Search in Google Scholar

132. Baskan EB, Yilmaz E, Saricaoglu H, Alkan G, Ercan I, Mistik R, et al. Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet’s disease. Clin Exp Dermatol. 2007; 32:186-90.10.1111/j.1365-2230.2006.02330.x17250756Search in Google Scholar

133. Touge C, Agawa H, Sairenji T, Inoue Y. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Arch Virol. 2006; 151: 895-903.10.1007/s00705-005-0686-716362642Open DOISearch in Google Scholar

134. Sun A, Chang JG, Chu CT, Liu BY, Yuan JH, Chiang CP. Preliminary evidence for an association of Epstein- Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behcet’s disease. J Oral Pathol Med. 1998; 27:168-75.10.1111/j.1600-0714.1998.tb01935.x9563572Search in Google Scholar

135. Rezaieyazdi Z, Shoja-e-razavi G. Interferon alfa-2b therapy in mucocutaneous manifestations of Behcet’s disease. Iran J Med Sci. 2005; 30:105-9.Search in Google Scholar

136. Buskila D, Gladman DD, Gilmore J, Salit IE. Behcet’s disease in a patient with immunodeficiency virus infection. Ann Rheum Dis. 1991; 50:115-6.10.1136/ard.50.2.11510043501998386Open DOISearch in Google Scholar

137. Mahajan V, Sharma NL, Sharma VC, Sharma RC, Sarin S. Behcet’s disease with HIV infection: Response to antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2005; 71:276-8.10.4103/0378-6323.1662316394440Search in Google Scholar

138. Hayasaka S, Noda S, Setogawa T. Increased Darabinitol/ creatinine ratio in sera of patients with Behcet’s disease during an active phase. Brit J Ophthalmol. 1993; 77:39-40.10.1136/bjo.77.1.395044218435398Open DOISearch in Google Scholar

139. Monselise A, Weinberger A, Monselise Y, Fraser A, Sulkes JF, Krause I. Anti-Saccharomyces cerevisiae antibodies in Behcet’s disease - a familial study. Clin Exp Rheumatol. 2006; 24:S87-90.Search in Google Scholar

140. Krause I, Monselise Y, Milo G, Weinberger A. Anti- Saccharomyces cerevisiae antibodies - A novel serologic marker for Behcet’s disease. Clin Exp Rheumatol. 2002; 20:S21-4.Search in Google Scholar

141. Fresko I, Ugurlu S, Ozbakir F, Celik A, Yurdakul S, Hamuryudan V, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet’s syndrome. Clin Exp Rheumatol. 2005; 23:S67-70.Search in Google Scholar

142. Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH, et al. Anti-Saccharomyces cerevisiae antibody in intestinal Behcet’s disease patients: relation to clinical course. Dis Colon Rectum. 2006; 49:1849-59.10.1007/s10350-006-0706-z17080284Open DOISearch in Google Scholar

143. Kim BG, Kim YS, Kim JS, Jung HC, Song IS. Diagnostic role of Anti-Saccharomyces cerevisiae Mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum. 2002; 45:1062-9.10.1007/s10350-004-6361-312195191Open DOISearch in Google Scholar

144. Krvavac S. Genitorectal trichomonas invasion as (co)-factor in pathogenesis of Behcet’s syndrome. Ann Rheum Dis. 1990; 49:423.10.1136/ard.49.6.423-a10041212383074Open DOISearch in Google Scholar

145. Behcet H. Uber rezidivierende, aphthose durch ein virus verursachte Geschwure am Mund, am Auge und am den Genitalen. Dermatol Wochenschr. 1937; 105:1152-7.Search in Google Scholar

146. Young C, Lehner T, Barnes CG. CD4 and CD8 cell responses to herpes simplex virus in Behcet’s disease. Clin Exp Immunol. 1988; 73:6-10.Search in Google Scholar

147. Hamzaoui K, Kahan A, Ayed K, Hamza M. Cytotoxic T cells against herpes simplex virus in Behcet’s disease. Clin Exp Immunol. 1990; 81:390-5.10.1111/j.1365-2249.1990.tb05344.x15349922168823Search in Google Scholar

148. Kotter I, Vonthein R, Gunaydin I, Muller CA, Zierhut M, Stubiger N. Behcet’s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol. 2004; 31:133-9.Search in Google Scholar

149. Okada AA. Behcet’s disease: general concepts and recent advances. Curr Opin Ophthalmol. 2006; 17: 551-6.10.1097/01.icu.0000247411.59213.bb17065924Open DOISearch in Google Scholar

150. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe. Yonsei Med J. 1997; 38:411-22.10.3349/ymj.1997.38.6.4119509911Open DOISearch in Google Scholar

151. Tazi Mezalek Z, Harmouche H, El Attar N, Serraj K, Aouni M, Adnaoui M, et al. Kaposi’s sarcoma in association with Behcet’s disease: case report and literature review. Semin Arthritis Rheum. 2007; 36: 328-31.10.1016/j.semarthrit.2006.11.00117240427Open DOISearch in Google Scholar

152. Auzary C, Du Boutin LTH, Wechsler B, Chollet P, Piette JC. Disseminated nocardiosis presenting as a flare of Behcet’s disease. Rheumatology. 2001; 40: 949-52.10.1093/rheumatology/40.8.94911511773Open DOISearch in Google Scholar

153. Pamuk GE, Pamuk ON, Tabak F, Mert A, Ozturk R, Aktuglu Y. Systemic Nocardia infection in a patient with Behcet’s disease. Rheumatology. 2001; 40:597-9.10.1093/rheumatology/40.5.59711371678Open DOISearch in Google Scholar

154. Korkmaz C, Aydinli A, Erol N, Yildirim N, Akgun Y, Inci R, et al. Widespread nocardiosis in two patients with Behcet’s disease. Clin Exp Rheumatol. 2001; 19: 459-62.Search in Google Scholar

155. Arslan U, Tuncer I, Uysal EB, Inci R. Pleuropulmonary and soft tissue Nocardia cyriacigeorgici infection in a patient with Behcet’s disease. Saudi Med J. 2007; 28:1435-7.Search in Google Scholar

156. Ueda M, Kobayashi Y, Yoshimori K, Takahashi Y, Chikayama S, Ikeda M, et al. [Epstein-Barr virusinfected T-cell malignancy in an adult patient with Behcet’s disease-like symptoms.] Jpn J Clin Hematol. 1997; 38:657-62. (in Japanese)Search in Google Scholar

157. Finsterer J, Schmidbauer M. Lethal fulminate S. aureus sepsis in M. Behcet overnight cold exposure. Acta Medica Austriaca. 2002; 29:143-5.10.1046/j.1563-2571.2002.02023.x12424941Open DOISearch in Google Scholar

158. Skvara H, Duschek N, Karlhofer F. De novo tuberculosis during infliximab therapy in a patient with Behcet disease. J German Soc Dermatol. 2009; 7:616-8.Search in Google Scholar

159. Raychaudhuri SP, Siu S. Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases. Brit J Dermatol. 1999; 141:528-30.10.1046/j.1365-2133.1999.03052.x10583061Open DOISearch in Google Scholar

160. Kotter I, Aepinus C, Graepler F, Gartner V, Eckstein AK, Stubiger N, et al. HHV8 associated Kaposi’s sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behcet’s disease and complete remission of both disorders with interferon á. Ann Rheum Dis. 2001; 60:83-6.10.1136/ard.60.1.83175336511114291Search in Google Scholar

161. Malkin J, Shrimpton A, Wiselka M, Barer MR, Duddridge M, Perera N. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet’s disease. J Med Microbiol. 2009; 58:371-3.10.1099/jmm.0.006809-019208889Open DOISearch in Google Scholar

162. Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, et al. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment. World J Gastroenterol. 2008; 14:2912-4.10.3748/wjg.14.2912271073718473420Open DOISearch in Google Scholar

163. Seddon ME, Thomas MG. Invasive disease due to Epidermophyton floccosum in an immunocompromised patient with Behcet’s syndrome. Clin Infect Dis. 1997; 25:153-4.10.1086/5168879243051Open DOISearch in Google Scholar

164. Cooper C, Pippard EC, Sharp H, Wickham C, Chamberlain MA, Barker DJP. Is Behcet’s disease triggered by childhood infection? Ann Rheum Dis. 1989; 48:421-3. 10.1136/ard.48.5.42110037732730167Open DOISearch in Google Scholar